NCT02772003 2026-03-19
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
50 trialsNCT03520660 2026-03-11
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06842563 2025-07-09
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Singlera Genomics Inc.
Active not recruiting
NCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT06745895 2024-12-20
MATCHES
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Recruiting
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT05184283 2023-12-07
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Terminated
NCT05498779 2023-11-28
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT04980157 2023-01-23
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT00375011 2022-12-20
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Meridian Bioscience, Inc.
Terminated
NCT04190498 2022-05-24
ECHAPS
University Hospital, Grenoble
Withdrawn
NCT05376943 2022-05-17
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Unknown
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT03200171 2021-07-21
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Completed
NCT03707080 2021-07-06
Direct Acting Antiviral-Post Authorization Safety Study
Target PharmaSolutions, Inc.
Completed
NCT03254121 2021-02-18
HEPCASUS
Karolinska Institutet
Completed
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT04546802 2020-09-14
HATCHeT
Bayside Health
Phase 3 Withdrawn
NCT04395118 2020-07-02
STOP-HCC
University of Texas Southwestern Medical Center
Phase NA Withdrawn
NCT00341705 2019-12-17
The Second Multicenter Hemophilia Cohort Study
National Institutes of Health Clinical Center (CC)
Completed
NCT00825877 2019-12-17
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
Completed
NCT01619475 2019-02-08
A2ALL-2
Arbor Research Collaborative for Health
Completed
NCT03775798 2018-12-19
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Austral University, Argentina
Unknown
NCT02833298 2018-10-12
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT00096733 2017-08-29
A2ALL-1
Arbor Research Collaborative for Health
Completed
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT01559844 2016-07-27
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Phase 2 Completed
NCT00767936 2016-06-29
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Terminated
NCT01831037 2015-01-28
ROLFH
University of Arkansas
Withdrawn
NCT01405183 2014-09-17
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Henry Ford Health System
Completed
NCT01022476 2013-07-18
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT01729221 2012-11-20
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
Cairo University
Unknown
NCT00768001 2012-02-01
Genetic Analysis of Liver Cancer
Stanford University
Terminated
NCT01355107 2011-12-14
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
University Hospital Freiburg
Completed
NCT01350167 2011-05-24
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
Minneapolis Veterans Affairs Medical Center
Phase NA Unknown
NCT00822991 2010-12-30
Sonazoid Enhanced Liver Cancer Trial for Early Detection
Kindai University
Phase NA Unknown
NCT00165633 2008-12-09
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
Eisai Inc.
Phase 2/3 Terminated
NCT00273247 2006-01-09
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan
Phase 3 Completed
NCT00154531 2005-12-20
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
National Taiwan University Hospital
Unknown